Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of TRENDS

被引:259
作者
Daoud, Emile G. [1 ]
Glotzer, Taya V. [2 ]
Wyse, D. George [3 ]
Ezekowitz, Michael D. [4 ]
Hilker, Christopher [5 ]
Koehler, Jodi [5 ]
Ziegler, Paul D. [5 ]
机构
[1] Ohio State Univ, DHLRI, Med Ctr, Ross Heart Hosp, Columbus, OH 43210 USA
[2] Hackensack Univ Med Ctr, Hackensack, NJ USA
[3] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada
[4] Lankenau Inst Med Res, Philadelphia, PA USA
[5] Medtronic Inc, Minneapolis, MN USA
关键词
Atrial fibrillation; Atrial tachyarrhythmia; Implantable cardiac device; Stroke; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; RISK STRATIFICATION; STROKE PREVENTION; PREDICTING STROKE; FOLLOW-UP; FIBRILLATION; RECOMMENDATIONS; THROMBOGENESIS; DESIGN;
D O I
10.1016/j.hrthm.2011.04.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The temporal relationship between atrial tachyarrhythmias (atrial tachycardia [AT] and atrial fibrillation [AF]) and cerebrovascular events/systemic emboli (CVE/SE) is unknown. OBJECTIVE The purpose of this study was to evaluate this relationship using stored AT/AF diagnostic data from implanted devices in patients with and those without AF. METHODS The TRENDS study enrolled 2,486 patients with an indication for an implantable device, at least one stroke risk factor, and available device data. The current study includes the subgroup of 40 (1.6%) patients enrolled in TRENDS who experienced CVE/SE. RESULTS AT/AF was detected prior to CVE/SE in 20 (50%) of 40 patients. Other than average and maximum daily AT/AF burden and duration of device monitoring prior to CVE/SE, no statistically significant differences were found between patients with and those without AT/AF prior to CVE/SE. For the 20 patients with AT/AF detected prior to CVE/SE, 9 (45%) did not have any AT/AF in the 30 days prior to CVE/SE. Therefore, 29 (73%) of 40 patients with CVE/SE had zero AT/AF burden within 30 days prior to CVE/SE. Fourteen (70%) of the 20 patients with AT/AF detected prior to CVE/SE were not in AT/AF at diagnosis of CVE/SE. The last episode of AT/AF in these 14 patients was 168 +/- 199 days (range 3-642 days) before CVE/SE. CONCLUSION The majority of CVE/SE in this population did not occur proximal to recent AT/AF episodes. These data imply that the mechanisms of CVE/SE in patients with implantable devices may importantly involve mechanisms other than cardioembolism due to atrial tachyarrhythmias.
引用
收藏
页码:1416 / 1423
页数:8
相关论文
共 30 条
  • [1] Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
    Adams, Robert J.
    Albers, Greg
    Alberts, Mark J.
    Benavente, Oscar
    Furie, Karen
    Goldstein, Larry B.
    Gorelick, Philip
    Halperin, Jonathan
    Harbaugh, Robert
    Johnston, S. Claiborne
    Katzan, Irene
    Kelly-Hayes, Margaret
    Kenton, Edgar J.
    Marks, Michael
    Sacco, Ralph L.
    Schwamm, Lee H.
    [J]. STROKE, 2008, 39 (05) : 1647 - 1652
  • [2] ANDERSON DC, 1992, ANN INTERN MED, V116, P6
  • [3] Patients with atrial fibrillation and dense spontaneous echo contrast at high risk -: A prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging
    Bernhardt, P
    Schmidt, H
    Hammerstingl, C
    Lüderitz, B
    Omran, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) : 1807 - 1812
  • [4] HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up
    Calkins, Hugh
    Brugada, Josep
    Packer, Douglas L.
    Cappato, Riccardo
    Chen, Shih-Ann
    Crijns, Harry J. G.
    Damiano, Ralph J., Jr.
    Davies, D. Wyn
    Haines, David E.
    Haissaguerre, Michel
    Iesaka, Yoshito
    Jackman, Warren
    Jais, Pierre
    Kottkamp, Hans
    Kuck, Karl Heinz
    Lindsay, Bruce D.
    Marchlinski, Francis E.
    McCarthy, Patrick M.
    Mont, J. Lluis
    Morady, Fred
    Nademanee, Koontawee
    Natale, Andrea
    Pappone, Carlo
    Prystowsky, Eric
    Raviele, Antonio
    Ruskin, Jeremy N.
    Shemin, Richard J.
    [J]. HEART RHYTHM, 2007, 4 (06) : 816 - 861
  • [5] Stroke Prevention in Atrial Fibrillation and Other Major Cardiac Sources of Embolism
    Freeman, William D.
    Aguilar, Maria I.
    [J]. NEUROLOGIC CLINICS, 2008, 26 (04) : 1129 - 1160
  • [6] ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
    Fuster, Valentin
    Ryden, Lars E.
    Cannom, David S.
    Crijns, Harry J.
    Curtis, Anne B.
    Ellenbogen, Kenneth A.
    Halperin, Jonathan L.
    Le Heuzey, Jean-Yves
    Kay, G. Neal
    Lowe, James E.
    Olsson, S. Bertil
    Prystowsky, Eric N.
    Tamargo, Juan Luis
    Wann, Samuel
    [J]. CIRCULATION, 2006, 114 (07) : E257 - E354
  • [7] Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
    Gage, BF
    Waterman, AD
    Shannon, W
    Boechler, M
    Rich, MW
    Radford, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22): : 2864 - 2870
  • [8] The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk The TRENDS Study
    Glotzer, Taya V.
    Daoud, Emile G.
    Wyse, D. George
    Singer, Daniel E.
    Ezekowitz, Michael D.
    Hilker, Christopher
    Miller, Clayton
    Qi, Dongfeng
    Ziegler, Paul D.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (05) : 474 - 480
  • [9] Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: The TRENDS study
    Glotzer, TV
    Daoud, EG
    Wyse, DG
    Singer, DE
    Holbrook, R
    Pruett, K
    Smith, K
    Hilker, CE
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2006, 15 (01) : 9 - 14
  • [10] Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice?
    Go, AS
    Hylek, EM
    Chang, YC
    Phillips, KA
    Henault, LE
    Capra, AM
    Jensvold, NG
    Selby, JV
    Singer, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20): : 2685 - 2692